The Digital Future is Now: Making Patient Choice a Reality

Discover why a digital clinical platform is the best path forward for patients, sites, and sponsors.

Register Free: https://www.pharmtech.com/pt_w/patient-choice

Event Overview

It’s no secret that the COVID-19 pandemic drove a rapid increase in the adoption of decentralized clinical trials (DCTs), which delivered ample benefits for sponsors, study teams and most importantly, patients. These benefits included:

• Simplifying the sponsor technology ecosystem with one enterprise solution.
• Reducing patient site visits by up to 75%.
• Accelerating enrollment timelines by 50%.
• Real-time data and insights.
• More diverse patient populations.

Now that many sponsors are embracing DCTs, these organizations must focus on scaling their approach to ensure long-term success and positive return on investment (ROI). To achieve scale, digital strategies must be embedded early into the pipeline of pharma and biotech companies, requiring the formation of standardized processes and partnerships that work together to achieve a common goal.
To find out more, watch this free webinar with experts from Medable, Gilead Sciences , Syneos Health, and Veeva. The panel discusses best practices and provides examples on how to implement and scale DCTs across large organizations while mitigating potential risks.

Key Learning Objectives

• Best practices for using digital technologies (ie, eConsent, eCOA, CTMS, eTMF, HHN, etc) and creating operational efficiencies in conjunction with existing processes across the product portfolio.
• Examples of how shifting from a study-by-study approach to an enterprise platform approach can maximize ROI from DCT technologies.
• How to re-think the end-to-end process and create the right ecosystem of partners to successfully scale a DCT strategy across an organization.

Who Should Attend

• Large Pharma Sponsors, Biotechs, & CROs
• Clinical operations/research/development professionals
• Therapeutic area lead professionals
• R&D IT / technology professionals
• Procurement/buying/outsourcing
• Founder/ President/ CEO/ Executive Directors
• Chief Medical Officers / Chief Scientific Officers/ Chief Innovation Officers
• Clinical trial strategy team professionals
• Data sciences & innovation
• Digital health professionals

Speakers

Sam Bavery
Senior Director, Strategy & Growth
Medable

Sam Bavery is the Senior Director of Strategy & Growth at Medable. In this role, Sam leads the effort to scale the use of digital capabilities with Medable’s customers and partners, focusing on standardization and automation to drive cycle time reduction and increase data quality. Prior to joining Medable in 2021, Sam spent over a decade at Accenture working in roles that span across the healthcare ecosystem—with a focus on developing solutions that bridge the gap between standard of care and clinical trials. Most recently, he led teams with multiple top 20 pharma companies in driving DCT strategies. Sam holds a Bachelor of Science degree in Computer Engineering from the University of Minnesota.

Claire Riches
Senior Vice President, Global Client Solutions
Syneos Health

Claire Riches is an industry veteran, with over 25 years’ experience in the clinical, pre/post approval, and commercial arena. Having worked in large pharma, biotech, and CRO settings, Claire currently oversees strategic partnerships at Syneos Health with focus on bringing innovation and value to her clients by leveraging the full enterprise offerings of Syneos Health and the wider industry, including strategic partners. Claire is passionate about optimizing patient experience, technology offerings, and ways of working to ensure clinical trial execution is optimized without sacrificing quality.

Juliet Hulse
Executive Director, Global RN Strategy and Patient Advocacy
Illingworth Research Group, a Syneos Health Company

Juliet Hulse is the Executive Director of Global RN Strategy and Patient Advocacy at Illingworth Research Group, a Syneos Health company. She joined the company in 2011. Juliet has over 20 years’ experience within clinical research, commencing her career in cardiology research covering multiple Phase I-IV trials. More recently, she has specialized in neurology research, in particular, the field of multiple sclerosis. Juliet has wide experience in the management of trial projects, from initiation to close out, as well as experience working with site investigators to improve patient recruitment and patient retention to study protocols. She believes developing a strategy that places the patient in the center of the trial is vital for a successful study.

Richard Young
Vice President, Strategy Vault CDMS
Veeva,

Richard Young is responsible for establishing Vault CDMS as the best-in-class solution for all data acquisition, management, and reporting purposes. This requires the considered provision of thought leadership, developing product and market strategy, and coordinating resources across the customer life cycle. With 25 years’ experience in Life Sciences, Richard is known for his keen executive vision and proven operational experience in data management, eClinical Solutions, and advanced clinical strategies.

Register Free: https://www.pharmtech.com/pt_w/patient-choice